FDC Share Price
Small Cap | Pharmaceuticals and health care | NSE: FDC | BSE: 531599
₹481.10 11.10 (2.36 %)
Last Updated: 01 Feb 2025 04:01 PM
Overview
Open (₹) 483.00
High (₹) 485.40
Low (₹) 470.10
Prev. Close (₹) 470.00
Volume 4,841
VWAP (₹) 471.93
ROCE (%) 18.55
Industry P/E 46.23
TTM P/E 24.74
P/B Ratio 3.75
Market Cap (₹) Cr.7,863.73
Dividend Yield (%)--
EPS (₹) 18.58
ROE14.42%
Sales Growth (%) 8.92
Profit Growth (%)57.39
Day Range
485.40485.40
52 Week Range
405.05659.00
Historical Returns
Returns (6M)
-3.06 %
Returns (1Y)
12.66 %
Returns (3Y)
64.45 %
Returns (5Y)
111.43 %
Returns (6M)
-3.06 %
Returns (1Y)
12.66 %
Returns (3Y)
64.45 %
Returns (5Y)
111.43 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with (59.35%) TTM EPS Growth
- Company with no debt
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Company with 59.35% positive TTM EPS growth
- Increasing Annual Revenue for Past 2 Years
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
RSI 62.17
MFI 52.26
ATR 15.69
Commodity Channel Index -58.85
ROC125 -7.68
ROC21 -5.78
Williams %R -56.19
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 477.16 | 484.33 | 489.41 | 472.08 | 464.91 | 459.83 | 452.66 |
Week Ago | 478.85 | 486.15 | 495.35 | 469.65 | 462.35 | 453.15 | 445.85 |
Month Ago | 502.80 | 506.75 | 512.55 | 497.00 | 493.05 | 487.25 | 483.30 |
EMA & SMA
481.10
Current Price
Bullish Moving Averages
10
Bearish Moving Averages
10
5 Day 473.28
9 Day 472.65
10 Day 473.91
12 Day 474.65
14 Day 475.92
20 Day 484.52
26 Day 487.48
50 Day 495.55
100 Day 519.46
200 Day 498.75
Deals & Announcements
Bulk and Block Deals
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
03 Apr, 2024 | Nomita Ramdas Chandavarkar | Acquisition | ₹ | 3,16,56,049 | BSE |
03 Apr, 2024 | Meera Ramdas Chandavarkar | Disposal | ₹ | 3,16,56,049 | BSE |
09 Jun, 2022 | Melarkode Ganesan Parmeswaran | Acquisition | ₹246.59 | 3,700 | BSE |
10 Oct, 2020 | MEERA R. CHANDAVARKAR | Disposal | ₹450.00 | 3,63,501 | BSE |
10 Oct, 2020 | ADITI C. BHANOT | Disposal | ₹450.00 | 12,755 | BSE |
10 Oct, 2020 | NOMITA R. CHANDAVARKAR | Disposal | ₹450.00 | 60,407 | BSE |
10 Oct, 2020 | NANDAN M. CHANDAVARKAR | Disposal | ₹450.00 | 57,886 | BSE |
10 Oct, 2020 | NANDAN M. CHANDAVARKAR in capacity of trustee of Sandhya Mohan Chandavarkar Trust | Disposal | ₹450.00 | 2,05,742 | BSE |
10 Oct, 2020 | AMEYA A. CHANDAVARKAR in capacity of Director of Virgo Advisors Private Limited | Disposal | ₹450.00 | 1,14,332 | BSE |
10 Oct, 2020 | ASHOK A. CHANDAVARKAR in capacity of Director of Leo Advisors Private Limited | Disposal | ₹450.00 | 1,71,497 | BSE |
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
07 Nov, 2024 | Rs.5.0000 per share(500%)First Interim Dividend | 22 Nov, 2024 | 22 Nov, 2024 |
09 Mar, 2020 | Rs.0.8000 per share(80%)Interim Dividend | 19 Mar, 2020 | 21 Mar, 2020 |
Announcements
Date | Source | Detail |
---|---|---|
31 Jan, 2025 | BSE India | Intimation under Regulation 30 of SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015 |
02 Jan, 2025 | NSE India | FDC Limited has informed the Exchange regarding ''Intimation of Change of Name of the RTA''. |
02 Jan, 2025 | BSE India | Intimation of Change in name of Company''s Registrar and Share Transfer Agent (RTA) from Link Intime India Private Limited to MUFG Intime India Private Limited |
26 Dec, 2024 | NSE India | FDC LIMITED has informed the Exchange about Issue of duplicate share certificates/Letter of Confirmation |
26 Dec, 2024 | NSE India | FDC Limited has informed the Exchange about Issue of Duplicate Share Certificate |
26 Dec, 2024 | NSE India | FDC LIMITED has informed the Exchange about Closure of Trading Window |
26 Dec, 2024 | NSE India | FDC Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
18 Dec, 2024 | NSE India | FDC Limited has informed the Exchange regarding '''' final approval from US FDA for the Company s Abbreviated New Drug Application (ANDA) for Cefixime 400 mg Tablets. |
18 Dec, 2024 | BSE India | Intimation regarding approval received from US FDA for ANDA - Cefixime 400 mg tablets |
13 Dec, 2024 | NSE India | FDC Limited has informed the Exchange about Loss of Share Certificates |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results & Other | To consider others business matters. | 30 Oct, 2024 | 06 Nov, 2024 |
Quarterly Results | -- | 29 Jul, 2024 | 07 Aug, 2024 |
Audited Results | -- | 21 May, 2024 | 29 May, 2024 |
Quarterly Results | -- | 30 Jan, 2024 | 07 Feb, 2024 |
Quarterly Results | -- | 02 Nov, 2023 | 08 Nov, 2023 |
Quarterly Results & Buy Back of shares | -- | 05 Aug, 2023 | 09 Aug, 2023 |
Audited Results | -- | 16 May, 2023 | 25 May, 2023 |
Quarterly Results | -- | 01 Feb, 2023 | 09 Feb, 2023 |
Quarterly Results | -- | 03 Nov, 2022 | 14 Nov, 2022 |
Quarterly Results | -- | 22 Jul, 2022 | 04 Aug, 2022 |
Share Holding Pattern
Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
---|
About FDC
FDC is a Public Limited Listed company incorporated on 23/09/1940 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1940PLC003176 and registration number is 003176. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1916.19 Cr. and Equity Capital is Rs. 16.28 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1940
Managing Director
Mr. Mohan A Chandavarkar
NSE Symbol
FDC
FDC Management
Name | Designation |
---|---|
CA. Uday Kumar Gurkar | Chairman & Ind.Director |
Mr. Mohan A Chandavarkar | Managing Director |
Mr. Nandan M Chandavarkar | Joint Managing Director |
Mr. Ameya A Chandavarkar | Executive Director & CEO |
Mr. Ashok A Chandavarkar | Executive Director |
Ms. Nomita R Chandavarkar | Non Exe.Non Ind.Director |
CA. Swati S Mayekar | Independent Director |
Dr. Mahesh Bijlani | Independent Director |
Mr. Vijay Maniar | Independent Director |
Mr. Vijay Nautamlal Bhatt | Independent Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
SunPhrmInds | ₹4,46,576.22 | ₹1,742.20 ₹1,743.95(-0.10%) | ₹1,249.800 - ₹1,960.200 |
Divis Labora | ₹1,56,123.40 | ₹5,618.55 ₹5,577.70(0.73%) | ₹3,350.050 - ₹6,448.750 |
Cipla | ₹1,21,675.13 | ₹1,439.50 ₹1,479.40(-2.70%) | ₹1,240.700 - ₹1,702.000 |
ManKind Phar | ₹1,18,478.90 | ₹2,481.60 ₹2,435.40(1.90%) | ₹1,910.100 - ₹3,050.000 |
DrReddysLab | ₹1,15,939.04 | ₹1,204.95 ₹1,217.35(-1.02%) | ₹1,104.690 - ₹1,420.200 |
FAQs on FDC
What is the share price of FDC?
The share price of FDC on 01 Feb, 2025 is ₹ 481.10.
What is 52W high and 52W low share price of FDC?
The highest and lowest 52W share prices of FDC are ₹ 659.000 and ₹ 390.450
What is the market cap of FDC?
The market capitalization of FDC as of 01 Feb, 2025 is ₹ 7,863.73 Crores
What is the P/E ratio of FDC?
The current P/E ratio of FDC as of 01 Feb, 2025 is 46.23
What is the PB ratio of FDC?
The PB ratio of FDC as of 01 Feb, 2025 is 3.75
Top Gainers
948IHFL26I
IBHFL NCD186
₹845
₹705 (0.2%)
GREAVESCOT
Greaves
₹281.85
₹234.9 (0.2%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.2%)
CAPRO
Caprola.Chem
₹62.4
₹52 (0.2%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.1%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.1%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0%)